Skip to main content
Clinical Trials/ISRCTN23894653
ISRCTN23894653Completed未知

A small randomised controlled trial on ST-MBCT + TAU versus COMET + TAU for patients with a personality disorder: effectiveness, predictors and mediators of outcome

GGZ Delfland0 sites58 target enrollmentStarted: September 13, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
58

Study Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31556633 (added 27/09/2019)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients (male or female) with a main diagnosis on Axis II, meaning one or more cluster A, B, C personality disorders or a personality disorder NOS
  • 2. Aged 18 to 65 years
  • 3. Patients were allowed to have a diagnosis on Axis I other than the exclusion criteria

Exclusion Criteria

  • 1. Acute psychosis
  • 2. Addiction of such severity that clinical detoxification was indicated
  • 3. Severe suicidality for which hospitalisation was necessary
  • 4. Untreated ADHD, bipolar I disorder and an IQ lower than 80
  • 5. Patients were not allowed to have had Schema therapy or COMET in the past 12 months

Investigators

Sponsor
GGZ Delfland

Similar Trials